
NAFDAC Bans Unregistered Batch of Tarivid Antibiotic Over Safety Concerns
The National Agency for Food and Drug Administration and Control (NAFDAC) has banned an unregistered batch of the antibacterial drug Tarivid (Ofloxacin 200mg), citing serious safety concerns after circulating in